Biotech Business - December 9, 2024
MetaCurUm secures SEK 1 million grant
MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.
Uncategorized - December 1, 2024
Mentice appoints new CEO
Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
Collaboration - September 14, 2024
Are you ready for Nordic Life Science Days 2024?
The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.
Clinical Trials - September 14, 2024
Evaxion reports 69% Overall Response Rate in its phase 2 trial
Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.
Uncategorized - June 28, 2023
New ATMP center at Lund University
Lund University is establishing a university-wide development center for advanced therapies, LU-ATMP. Advanced Therapy Medicinal Products (ATMP) are medicines that are based on cells, tissues or genes. With ATMP, injuries and illnesses can be treated in completely new ways and provide better opportunities to relieve and, to a progressively greater extent, cure a wide range […]
Uncategorized - November 3, 2022
Risk genes for idiopathic pulmonary fibrosis revealed
A Finnish-led international research team has discovered novel gene variants that increase the risk of a rare but severe lung disease, idiopathic pulmonary fibrosis. The results also demonstrate notable genetic similarities with susceptibility to severe COVID-19 infection, reports HiLIFE. The study, led by the University of Helsinki, identified seven previously novel genetic risk factors. Only […]
